MetaCap

Braveheart Bio (BRVE) News

NASDAQ: BRVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

20.39+1.12 (+5.81%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BRVE news summary

We found 6 recent headlines mentioning Braveheart Bio (BRVE): 0 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Seeking Alpha. BRVE is making an outsized move today, up 5.81% at $20.39, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Braveheart Bio, Inc. GAAP EPS of -$0.51 misses by $0.07", was published by Seeking Alpha on Nov 10, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Braveheart Bio headlines

Compare BRVE